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KAJIAN SEMULA LIMA TAHUN MENGENAI KOMPLIKASI IMPLANTED VENOUS 
ACCESS DEVICE (IVAD) DALAM PESAKIT KANSER MELALUI CEPHALIC VEIN 
CUT DOWN APPROACH 
 
Pengenalan: Implanted venous access device (IVAD)merupakan salah satu kaedah yang 
membolehkan capaian terus kepada peredaran vena pusat. Kaedah ini digunakan secara 
meluas pada masakini dan ianya boleh digunakan bagi pelbagai tujuan disamping ianya boleh 
di kekalkan di dalam badan pesakit sehingga 2 tahun. IVAD memerlukan penjagaan yang 
minima dan risiko komplikasi terutamanya jangkitan kuman yang rendah menyebabkan ia 
sesuai untuk kegunaan pesakit terutamanya kepada pesakit yang mempunyai kesukaran 
mendapat laluan salur darah seperti pesakit kanser. “Cephalic vein cut down approach” 
adalah salah satu cara untuk memasukkan IVAD kepada pesakit. Kaedah ini mempunyai 
risiko komplikasi yang rendah, tetapi ianya jarang digunakan kerana memerlukan 
pembedahan dan mengambil masa yang panjang. Kajian ini adalah untuk menilai komplikasi-
komplikasi alat IVAD yang diimplantasikandi dalam pesakit kanser melalui kaedah “cephalic 
vein cut down approach”. 
Kaedah Kajian: Kajian ini merupakan kajian retrospektif melibatkan pesakit kanser yang 
diimplantasi dengan IVAD melalui kaedah “cephalic vein cut down approach” di HUSM 
dari Januari 2010 hingga Disember 2014. Rekod pesakit di kaji dan penilaian untuk 
demografi, kaedah pembedahan, jenis alat IVAD, komplikasi-komplikasi selepas implantasi 
IVAD dan factor-faktor yang berkait rapat dengan komplikasi yang dianalisa. Semua 




Keputusan: Kajian ini melibatkan 197 pesakit dimana 54.3% merupakan pesakit lelaki dan 
45.7% adalah pesakit perempuan. Pembedahan dilakukan oleh Pakar Bedah Tulang keatas 
sebanyak 132 (67%) pesakit dan selebihnya 65 (33%) pesakit dilakukan oleh pegawai 
perubatan. Kesemua pesakit mendapat antibiotik sebelum pembedahan sebagai langkah 
pencegahan. Secara purata, tempoh pembedahan adalah selama 59.37 minit dan purata 
tempoh masa rawatan susulan yang juga merupakan tempoh alat IVAD berada di dalam 
badan pesakit adalah selama 715 hari. Komplikasi keseluruhan adalah sebanyak 12.7%. 
manakala komplikasi secara khusus adalah 0.5% (n=1) iaitu kedudukan yag salah alat IVAD, 
7.6% (n=15) jangkitan kuman, 3.6% (n=7) penyumbatan alat dan 1.0% (n= 2)kepatahan dan 
beralih kedudukan. Tiada kaitansignifikan diantara jenis tiub alat IVAD dengan komplikasi 
keseluruhan. Terdapat kaitandiantara jenis kanser dengan kadar jangkitan kuman. Kami juga 
menemui tiada kaitandiantara foktor umur dan “Absolute Neutrophil Count (ANC)” dengan 
kadarjangkitan kumandan diantara bilangan platelet dengan kadar penyumbatan alat IVAD.  
Kesimpulan:  “Cephalic vein cut down approach”adalah kaedah yang selamat untuk 
implantasi IVAD dengan kadar komplikasi keseluruhan yang rendah, Rawatan ini 











A RETROSPECTIVE FIVE YEARS REVIEW OF COMPLICATIONS OF 
IMPLANTABLE VENOUS ACCESS DEVICES (IVAD) IN CANCER PATIENT 
THROUGH THE CEPHALIC VEIN CUT DOWN APPROACH 
 
Introduction: Implanted venous access device (IVAD) is one of the options that give access 
to the central venous circulation. It is widely used nowadays and can be used for various 
reasons. It can be retained in the body for a period of up to two years with minimal care and 
low risk of infection thus it is suitable for patients especially for those who had the difficult 
vascular access example in cancer patients. Cephalic vein cut down approach is one of the 
methods of insertion of IVAD with minimal complication associated to this technique, 
however, it is not widely used as it needs to be done in operating theatre setting and it took 
longer duration. This study was done to evaluate the complication of the IVAD that 
implanted in cancer patient through cephalic vein cut down approach. 
 
 
Methodology: This is a retrospective study involving cancer patients that were implanted 
with IVAD through cephalic vein cut-down approach in HUSM from January 2010 to 
December 2014. All medical records reviewed and evaluated for demographics, surgical 
procedure, and types of IVAD, complications post implantation and possible associated 
factors with the complications studied. All the information collected and analyzed with SPSS 
programme 22.0.   
ix 
 
Results: There were 197 patients included in this study which involved 54.3% male patients 
and 45.7% female patients. The procedure performed by orthopaedic surgeons in 132(67%) 
patients, 65 patients (33%) performed by the medical officers. All patients received 
intravenous antibiotic prophylaxis, Cefuroxime prior to implantation. The mean duration of 
surgery was 59.37 minutes while the mean duration of follow up, was 715 days. The overall 
complication rate was 12.7% (n= 25). There were 7.6% (n=15) infection rate, 3.6% (n=7) 
thrombosis, 1.0% (n= 2) for fracture and migration and 0.5% (n=1) mal-position of IVAD. 
There was no association between the types of catheter with the overall complication rate. 
There was an association between the types of cancer with the infections rate. We found no 
association between age and absolute neutrophil count (ANC) with the infection rates and the 
platelet levels with thrombosis rates. 
Conclusions: Cephalic vein cut down approach is a safe approach for IVAD implantation 
with an overall low rate of complications. These treatments offer an alternative and provide 


















Implanted venous access device (IVAD) is a device implanted subcutaneously, which 
can give access to the central venous circulation. IVAD is also known as an indwelling 
central access device, port-A-cath, port or chemoport. It has 2 components which are a port 
body and a catheter. Aport body is implanted subcutaneously and connected with the 
catheter. The tip of the catheter is placed in the central venous circulation. The ideal location 
of the tip of the catheter is at the junction between superior vena cava and right atrium.  
 
 
Images courtesy of Bard® adopted from Central Venous Catheters In Adult Patients, a Self-
Learning Module by Patty Hignell, RN, BSN, MN, ENC(C) Vascular Access Clinical 
Practice Committee Fraser Health Authority October 2016 – Version 8 
 







There are two type of catheter tip which is closed-ended and open-ended tip. A 
closed-ended tip has a valve which is open during the infusion of the fluid into the IVAD 
only whereas open-ended tip doesn't have a valve, so it is open all the time and can cause a 
backflow of the blood into the catheter.The valve allows infusion and blood aspiration while 
reducing the risk of air embolism, blood reflux, and clotting.Negative pressure opens the 
valve inward, permitting blood aspiration, positive pressure opens the valve outward, 
allowing infusion. In a neutral pressure the valve remains closed, so there is no movement of 









Images courtesy of Bard® adopted from Central Venous Catheters In Adult Patients, a Self-
Learning Module by Patty Hignell, RN, BSN, MN, ENC(C) Vascular Access Clinical 
Practice Committee Fraser Health Authority October 2016 – Version 8 
Figure 2: Figure shows the differences between closed-ended and open-ended catheter. 
The closed-ended catheter has a valve that control the opening of the catheter. The 
open-ended catheter doesn’thave the valve thus it remains open all the time. 
 
There is various type of IVAD in the market, depending on the manufacturer. 
Examples are Bardport, Cellsite, Port A Cath, and Power Port. Each type of IVAD have both 
types of catheter, closed-ended and open-ended.  
Closed Ended Tip Open Ended Tip 
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Implanted venous access devices (IVAD) can be inserted using a percutaneous 
technique orsurgical technique. The percutaneous technique usually is done via a Seldinger 
technique and guided by ultrasound. This technique is commonly used because of a shorter 
duration of implantation and not involved with operating suite. Surgical techniqueby venous 
cut down approach was introduced because percutaneous technique was reportedto be 
associated with incidence of pneumothorax, bleeding, arterial puncture and hematoma.Many 
different venous sites can be used as an entry point for the IVAD including the external 
jugular vein, the internal jugular vein, the axillary vein, femoral vein and cephalic vein. A 
venous cut down approach is usually performed through a cephalic vein, whereas 








Figure 3: Various insertion site of IVAD 
Images adopted from Central Venous Catheters In Adult Patients, a Self-Learning Module by 
Patty Hignell, RN, BSN, MN, ENC(C) Vascular Access Clinical Practice Committee Fraser 
Health Authority October 2016 – Version 8 
 
Internal jugular vein approach Subclavian vein approach 
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The cephalic venous cut-down method has been widely described as a safe and rapid 
approach. Cephalic venous cut-down techniques when compared to the other vascular access 
were associated with a lower rate of catheter related complications (Hsu CCT et al., 2016). 
However, this technique is not widely used for the placement of IVAD (Shinichiro Koketsuet 
al., 2010). Cephalic venous cut down approach was performed in the operation theater. It can 
be done both under general anesthesia or local anesthesia. The cephalic vein passes through 
the clavipectoral (deltopectoral) triangle to join the axillary vein. A 3-cm wide skin incision 
was made in the infraclavicular region between the pectoralis major muscle and the deltoid 
muscle. The cephalic vein is identified in the adipose tissue along the deltopectoral groove. 
An venotomy is done to insert the catheter.The port was implanted in the subcutaneous space 
over the anterior chest wall at least 2.5cm away from the incision. The position of the catheter 
tip is confirmed by X-ray intraoperatively. 
IVAD can be used for various reasons such as administration of medication, 
continuous infusion of intravenous vesicants, and also for blood drawing. It can be retained in 
the body for a period of up to two years with minimal care (Narendra H et al., 2016). Due to 
its advantages, it gives benefits to the management of a patient with a chronic disease that 
requires prolonged intravenous access, especially for the cancer patient who had difficulties 
in peripheral venous access. It does not restrict the mobility of patient and needs minimal 
maintenance post-implantation. 
However, the use of central venous catheters is associated with adverse events that are 
both hazardous to the patients and an expensive to treat (Petit et al.,1994). A long term study 
showed that 13% of IVAD were removed due to complications, (Jorge et al.,1996). Special 
care needs to be taken to prevent the complication of IVAD due to increased risk of mortality 
of patient, increased cost of medical treatment and prolonged hospital stay (GukJinet al., 
2013). In Malaysia, a study reported that 19 patients (22.1%) out of 86 patient developed 
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complication after IVAD insertion, four patients who developed complications 
neededremoval of the implant. (Lim et al., 1996) 
Complications of the chemo-port insertion included malposition, bleeding, 
pneumothorax, thrombotic complications (native venous or port-catheter thrombosis), 
infections (tunnel or pocket infections or catheter-associated bloodstream infections), device 
fracture and migration, and extravasations of fluid (R. Biffiet al., 1997). Device fracture and 
migration describe as catheter dislodge from the body and migrate. 
The purpose of this study is to evaluate the outcome and complication of the IVAD 















































2.1. COMPLICATION OF IVAD 
Implanted venous access device (IVAD) provide a better central venous access to the 
patient. Since the introduction of the IVAD in 1982, the evolution of the IVAD provides 
extra benefit to the patient and the use of IVAD became more popular. IVAD are frequently 
used in patients who have poor peripheral venous access and are in need of long-term 
administration of vesicant drugs, antimicrobials, blood products, or parenteral nutrition.IVAD 
provide multiple advantages; patients have improved perceptions of quality of life and body 
image and less limitation in their mobility. These ports also minimize the need for 
maintenance care and risk of infectious complications when the IVAD is not in use. These 
benefits of IVAD port use have also been demonstrated in pediatric cancer patients, with the 
added advantage of allowing the child to participate in normal activities and preserving body 
image(Blanco guzmanet al, 2018). 
Despite the evolution and improvement with the IVAD, including the material used 
and insertion technique, the complication from the IVAD still happened. The use of central 
venous catheters is associated with adverse events that are both hazardous to patients and 
expensive to treat (Petit et al.,1994). Complication from the IVAD caused morbidity to the 
patient, hospital admission, prolonged hospital stay, delayed treatment, can lead to 
bacteremia and in worst case scenario can lead to sepsis and death. Complications of IVAD 
were associated with additional morbidity and cost and require removal of the IVAD as a part 
of their treatment in as many as 6.5% of patient (Blanco guzmanet al., 2018). Special care 
needs to be taken to prevent the complication of IVAD due to increased risk of mortality of 
patient, increased cost of medical treatment and prolonged hospital stay (GukJinet al., 
2013).A study entitled ‘Totally Implanted Device for Long-Term Intravenous Chemotherapy: 
Experience in 123 Adult Patients with Solid Neoplasm’, showedthat a total of 113 devices 
were removed during the period of study. Out of 113 devices, only 27% were for completion 
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of therapy, 60% were removed due to patient death and 13% were removed due to 
complications conducted by (Jorge et al., 1996). A local study in Malaysia reported that 19 
patients (22.1%) out of 86 patient developed complications after IVAD insertion, four 
patients who developed complications need removal of the IVAD(Lim et al., 1996). 
The complication was classified as an early or perioperative complication and late 
complication. The classification was made based on the time of the implantation to the time 
of the first usage of IVAD as early or perioperative and time from the first usage throughout 
the implantation period as late. Complications were divided into two main categories: (1) 
early (intra-operative and post-implantation period to first use); and (2) late complications 
(occurring after the first chemotherapy course given through the device) (Biffiet al., 1997). 
Complications were classified into immediate /early (intraoperative and postoperative before 
catheter use) and late (those occurring after the use of the catheter)(Esmalio Barroso et al., 
2012). The latest classification classified early complication as any complication that occurs 
within the period of 30 days post implantation and late complication occur after 30 days post-
implantation(Blanco Guzman et al., 2018). Despite the difference in the timeframe of early 
and late complication, all of the literature stated that early or peri-operative complication was 
a haematoma, bleeding, primary technical failure, malposition, and pneumothorax. For the 
late complication, there is an infection, catheter-related thrombosis, catheter fracture and 
migration and extravasation of the chemotherapy agent. 
There are numerous literature studying the outcome of the IVAD. The overall 
complication rate recorded was 3 – 21 % for the early complication and 5 – 33.7 % for late 
complication. (Barbetakiset al.,2011). Earlier studies conducted in 1996, which is study of 
the 169 catheters, the peri- and postoperative complication rate were low, although 
pneumothorax occurred in 6 patients (3.6%) while major complications occurred during 
treatment,with infection in 4 patients (2.4%), occlusion in 3 (l.8%), thrombosis in 8 (4.7%), 
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extravasationin 8 (4.7%) and migration in 3 (1.8%) (Poorteret al., 1996).Other literature later 
showedsimilar result.Early complications included six pneumothoraxes, three arterial 
punctures and two revisions for port and/or catheter malfunction (overall early complications 
in 8 patients). Late complications included 3 cases (1.68% of devices) of catheter rupture and 
embolization (0.093 episodes/l000 days of use), 2 cases (1.12% of devices) of venous 
thrombosis (0.062 episodes/l000 days of use), 1 case (0.56% of devices) of pocket infection 
(0.031 episodes/l000 days of use), and 4 cases (2.24% of devices) of port-related bacteremia 
(0.124 episodes/l000 days of use)(Biffiet al., 1997).Perioperative complications occurred in 
27 (21.4%) of 126 implanted IVADs: catheter malposition (16.7%) in 21 patients, 
pneumothorax (0.8%) in one and hemorrhage (4.0%) in five. Long-term complications 
appeared in 31 (25.2%) out of 123 IVAD: thrombosis in 9 (7.3%), especially associated with 
malposition of the tip of the catheter; infection in 10 (8.1%); extravasation in 2 (1.6%); 
migration of the catheter tip in 6 (4.8%); pain at reservoir in 3 (2.4%) and inaccessibility of 
the port in 1 (0.8%)(Hartkampet al., 2000).A retrospective analysis of 225 catheter and port 
system implantations detected long-term complications in 6.6% of cases: infection (2.2%), 
thrombosis (1.3%), extravasation (1.3%) and catheter fracture (1.8%) (Yildizeli et al., 
2004).In 45 consecutive patients there were 12 peri-operative adverse events in 45 procedures 
(27%): 3 pneumothoraces (7%), 3 hematomas (7%), 6 arterial punctures (13%). There was no 
air embolism, hemothorax, hemomediastinum, lesion of the thoracic duct or nerve palsy 
(StéphaneTercieret al., 2008). 
When focusing on the late complication, most of the literature stated that the most 
common complication was infection and thrombosis. After 30 days, infectious and 
thrombotic issues dominate port complications. Reported rate of long-term venous access 
infections ranged from 0.6 to 27%; depending on catheter location, catheter type and immune 
status of the patient(Yildizeliet al., 2004). Other late complications of IVAD were 
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low.Spontaneous fracture of the catheter and migration of a catheter fragment is a rare 
complication (Jensen MOet al., 2008). The incidence of catheter fracture in recent series 
varies from 0.4% to 1.8% (Filippou et al., 2004). The incidence of port catheter dislodgement 
with subsequent migration to the heart is low with an estimated rate of up to 0.4% (Chaung et 
al., 2011). Skin erosion has been reported in 0 to 1% of cases in the literature (Lorch et al., 
2001). Most of the literature concentrates on the infection and thrombosis in the IVAD 
patient because this cause a significant morbidity and affect patient management comparedto 
other complication. Port-related infections and venous thrombosis are particularly important 
because they are associated with additional morbidity and costs and require removal of the 
IVAD as part of their treatment in as many as 6.5% of patients(Blanco guzmanet al., 2018). 
2.2 Open Ended and Closed Ended Catheter Tip 
Closed-ended tip catheter was introducing in 1978, named as a groshong catheter that 
has a valve at the end of the tip. The valve opens only with the positive or negative pressure 
inside the catheter and remain closed in neutral pressure, thus preventing backflow of the 
blood into the catheter when we are not in use. A trial by Biffi and colleagues in 1997 
showed a low incidence of major complication related to implantation using closed-ended tip 
of catheter compared to open-ended tip. However, this study reported a significantly higher 
rate of withdrawal difficulties with the valvedGroshong catheter versus the open-ended 
catheter (12.5 vs. 2%; p<0.001) (R.Biffiet al., 1997).A recent study conducted in 2014 using 
Groshongcatheters with standardized insertion technique and catheter sizes again 
demonstrated higher rates of withdrawal failure in the valved catheters (24 vs. 0%; p<0.001). 
Based on the available data, Groshongvalved catheters do not appear to provide an advantage 
in terms of clotting or occlusion and have no significant differences in terms of other major 
complications, such as infection or thrombosis, compared with their non-valved 
counterparts(Zotteleet al., 2014). 
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2.3 Percutaneous Technique versus Cephalic Vein Cut Down Approach 
Percutaneous insertion of IVAD was noted to have more overall complication 
compared with a cephalic vein cut down approach. This is supported by the various study of 
IVAD. A study of358 venous access devices showed an overall complication rate of 14%. In 
lines successfully placed percutaneously, the complication rate was 15% (25 of 163) 
compared to 11% (16 of 148) in the successful cephalic cut-down group. Complications 
including pneumothorax, late catheter transection, and bradycardiawhich occurred only in 
percutaneously placed lines(Jablonet al., 2001). A study entitled ‘Outcome of cephalic vein 
cut-down approach: A safe and feasible approach for totally implantable venous access 
device placement’ showed no intraoperative or postoperative complications(Shinichiro et al., 
2010). Therefore, the CVCD approach is a safe and feasible method for IVAD placement. 
Another study compared percutaneous technique with the cephalic vein cut-down approach 
also showed a similar result. Complication rates of infection, pneumothorax, and catheter 
complications were analyzed, the Seldinger technique (subclavian vein access) was 
associated with a higher rate of catheter complications compared to the venous cut-down 
technique(Charlie Hsuiet al, 2016). 
However, multiple studies including a recent meta-analysis of 1006 patients, 
demonstrated no difference in the overall rate of complications (including hemothorax, 
pneumothorax, infection, catheterthrombosis, stenosis, kinking or extravasation, migrationof 
the catheter or dislodging of the port reservoir, hematoma, seroma, nerve palsy, thoracic duct 
injury, and death) or, in particular, in the rates of infection with either technique. It is worth 
noting that, when the analysis was limited to a subclavian site for the PT group, there was a 
higher rate of catheter-related complications (thrombosis, fibrin sheath, stenosis, kinking, 
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extravasation, migration of the catheter, or dislodgement of the reservoir) compared with 
cephalic vein cut down approach (Blanco Guzman et al., 2018). 
 
2.4 Risk Factor for Early Complication 
Early complications were due to mechanical issue related to catheter 
implantation(Blanco Guzman et al., 2018). The duration of surgical procedure during the 
implantation and number of catheterization attempt increase the risk of early complication 
(Barbetakiset al., 2011). Apart from that, a risk of mal-position, pneumothorax, and the 
hematoma is increased in a patient who had IVAD implanted by the resident officer 
(Poorteret al., 1996).With the introduction of the ultrasound, the early complication was 
markedlyreduced in the percutaneous technique of IVAD implantation.Short-term 
complications of port placement, such as malposition, hematoma formation, and 
pneumothorax, are practically nonexistent due to the routine use of ultrasound and 
fluoroscopic guidance during these procedures (Walser et al., 2012). In adding to that, early 
complication can be controlled with the cephalic vein cut-down approach. No incidence of 
mal-position, pneumothorax, and hematoma were noted when catheters were placed through 








2.5 Risk Factor for Infection 
The 4 major risk factors associated with catheter-related infections are host factors, 
catheter type, duration of use, and catheter maintenance and management(Aparnaet al., 
2015). 
Multivariate analysis identified monthly catheter-stay as a risk factor for CVP-BSI 
(p=0.000), however, its risk was lower in primary gastrointestinal cancer than in other cancer 
(p=0.002) (GukJin Lee et al., 2013). 
Incidences of infection were seemingly higher in the patients who received the 
procedure during inpatient treatment (p = 0.016), the patients with hematologic malignancy 
(p = 0.041), and the patients receiving palliative chemotherapy (p = 0.022). From the multiple 
binary logistic regression, the adjusted odds ratios of infection in patients with hematologic 
malignancies and those receiving palliative chemotherapy were 7.769 (p = 0.001) and 4.863 
(p = 0.003) respectively(Jisue Shimet al., 2012) 
The rate of catheter-related infections in long-term central venous access catheters 
ranges from 0.6 to 27%, depending on the catheter type and location and the patient’s 
constitution. Immunosuppressed patients with port systems were found to have a median of 
0.2 infections per 1000 catheter-days (range 0–2.7 per 1000 catheter-days) (Bouza et al, 
2002). 
The absolute number of circulating segmented neutrophils (absolute neutrophil count; 
ANC) is a predictor of infection risk. As the ANC falls below 1 x 106/l, susceptibility to 




2.6 Risk factor for thrombosis 
Patients with malignancies have various nonspecific thromboembolic risk factors 
(age, malignancy, hypercoagulability, chemotherapy, infections, and immobility) and specific 
risk factors such as catheter material, multiple placement attempts, catheter size and length, 
number of lumens, and catheter tip localization (Aparnaet al., 2015). 
Thrombosis is secondary to central venous catheters and cancer-related hyper-
coagulable state.Regarding the catheter, there is chemical structure, diameter, number of 
lumens, position the catheter tip, insertion side, implantation technique, prior use of central 
venous access and catheter-related infections.Patients’ characteristics include: platelet count, 
presence and type of malignancy, chemotherapy protocol and hyper-coagulable 
states(Esmalio Barroso et al., 2012) 
Thrombotic sequelae of ports occur in two forms: (1) stenosis or occlusion of the host 
vein due to trauma to the venous wall and (2) catheter tip thrombus from intravascular protein 
and cell deposition. The latter process begins almost immediately after catheter placement 
when albumin, lipoprotein, and fibrinogen create a protein sleeve around fresh intravascular 
catheters within 24 h of placement. Eventually, coagulation factors and platelets congregate 
to completely envelop the catheter (Beathardet al., 2001). 
There was a higher risk of venous thrombosis events among participants with 
abnormal plateletcount (Johanna G. van deret al., 2009). 
Four prospective studies of catheter-associated thrombosis in patients with solid 
tumors and hematological malignancies report rates of thromboembolic events between 37% 
and 66% (Bern et al., 1990). 
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The optimal position for port catheter tip placement is at the cavoatrial junction, 















































3.1. GENERAL OBJECTIVES 
1.To determine the complication that occur in cancer patients who were implanted with 
IVAD through the cephalic vein cut down 
3.2. SPECIFIC OBJECTIVES 
1.To determine the rate of malposition of device, bleeding, pneumothorax, thrombotic, 
infections, fracture and migration of catheter, extravasation after IVAD insertion. 
2. To compare the complication rate between the open-ended tip and closed-ended tip of 
IVAD 
3. To determine the risk factor associated with infection post-implantation of IVAD 




























4.1. Study Design 
This is a retrospective cohort study design. 
4.2. Study Sample 
All cancer patient who was implanted with IVAD through cephalic vein cut-down approach 
in HUSM from January 2010 to December 2014 and fulfilled the inclusion and exclusion 
criteria 
4.3. Setting of Study 
This study was carried out in Orthopaedic Department Hospital University Malaysia, 
KubangKerian, Kelantan.  
4.4. Sample Size 
Universal sampling method involving all patient who fulfilled the inclusion and exclusion 
criteria were included in the study 
4.5. Inclusion / Exclusion criteria 
Inclusion criteria:    
• All cancer patient that were implanted with IVAD through the cephalic vein cut-down 
approach.  
Exclusion criteria:  
• Non-cancer patient who was implanted with IVAD 
• A patient who was implanted with IVAD via other than cephalic vein cut-down approach 
• An incomplete medical record for 30 % of variables. 
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4.6. Methods of data collection 
This is a single center retrospective study that was conducted in Hospital University Sains 
Malaysia involving all cancer patients who were implanted with IVAD from January 2010 
until December 2014. All patients with retrievable medical records that have fulfilled the 
inclusion and exclusion criteria will be included in this study. 
Patient demographic data; age, sex, type of cancer, type of IVAD used, pre-operativeblood 
parameter, duration of surgical procedure will be recorded. 
Plain chest radiograph post-implantation of IVAD will be reviewed to determine the location 
of the tip of the catheter of IVAD 
The information related to the risk factor of a complication will be recorded, they are: 
Level of experience of a surgeon that performed IVAD 
Antibiotic prophylaxis 
Position of catheter 
All the complications that occurred to the patient will be recorded. 
Complication; is defined according to Clavien’s classification as a deviation from the 
standard postoperative course requiring intervention 
Complications of IVAD are a pneumothorax, malposition of the catheter, hematoma 





The complication was diagnosed based on: 
Pneumothorax was diagnosed based on collapsed of the lung in X-ray post-
operatively. 
A hematoma is a macroscopic subcutaneous blood collection without infection 
(Christoph et al 2006). 
Thrombosis is diagnosed when there is an inability to infuse and/or aspirate of the 
device ( Jablon et al,. 2006). 
Infections were classified according to the definition by the Centers for Disease 
Control and Prevention (CDC). A catheter-related bloodstream infection is defining as at 
least one positive blood culture from a peripheral vein and no other apparent source. 
Apositive culture for the catheter segment and a peripheral blood sample was a differential 
period of central venous port culture versus peripheral blood culture positivity of 2 hours. 
The isolation of similar organism from central and peripheral blood shows no other apparent 
source of infection. Port pocket infection is defined as an induration, erythema, and 
tenderness around the port with culture-positive material aspirated from the port pocket. 
Cutaneous site infection was defined as induration, erythema or tenderness and exudate at the 
port surface needle access site.  
Catheter fracture and migration are based on the changes of the position of the 
catheter with respect to prior X-ray (Christoph et al 2006). 




4.7. Statistical Method 
Using IBM SPSS statistic 22.0 (Dupont and Plummer, 2014) 
Data entry 
Descriptive analysis of numerical data as mean or median 
Multiple logistic regressionsanalysis was used to find the association between risk factor and 
complication.  
4.8. Ethical Issues 
Ethical approval was obtained prior to the commencement of the study. The researcher was 
the only person able to assess the name of patients to maintain data confidentiality. 
 
 
 
 
 
 
 
 
 
 
 24
 
Chapter 5 
 
RESULT 
 
 
 
 
 
 
 
 
 
